Literature DB >> 26043141

Neurofibromatosis type 2.

William H Slattery1.   

Abstract

Neurofibromatosis type 2 (NF2) is a rare syndrome characterized by bilateral vestibular schwannomas, multiple meningiomas, cranial nerve tumors, spinal tumors, and eye abnormalities. NF2 presents unique challenges to the otologist because hearing loss may be the presenting complaint leading to the diagnosis of the disorder. Care of patients with NF2 requires knowledge of all tumors and symptoms involved with the disorder. It is recommended that patients receive care in a center with expertise in NF2. The role of the neuro-otologist in this care is determined by the specialty center.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acoustic neuroma; Neurofibromatosis type 2; Vestibular schwannoma

Mesh:

Year:  2015        PMID: 26043141     DOI: 10.1016/j.otc.2015.02.005

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  10 in total

Review 1.  Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis comparable with mechanisms seen in inflammatory pathways? Part I: historical observations and clinical perspectives on the etiology of increased CSF protein levels, CSF clotting, and communicating hydrocephalus: a comprehensive review.

Authors:  Yosef Laviv; Burkhard S Kasper; Ekkehard M Kasper
Journal:  Neurosurg Rev       Date:  2017-03-07       Impact factor: 3.042

Review 2.  Syndromic Hearing Loss: A Brief Review of Common Presentations and Genetics.

Authors:  John D Gettelfinger; John P Dahl
Journal:  J Pediatr Genet       Date:  2018-01-04

3.  Auditory and audio-visual processing in patients with cochlear, auditory brainstem, and auditory midbrain implants: An EEG study.

Authors:  Irina Schierholz; Mareike Finke; Andrej Kral; Andreas Büchner; Stefan Rach; Thomas Lenarz; Reinhard Dengler; Pascale Sandmann
Journal:  Hum Brain Mapp       Date:  2017-01-28       Impact factor: 5.038

Review 4.  The Management and Imaging of Vestibular Schwannomas.

Authors:  E P Lin; B T Crane
Journal:  AJNR Am J Neuroradiol       Date:  2017-05-25       Impact factor: 3.825

Review 5.  A Critical Overview of Targeted Therapies for Vestibular Schwannoma.

Authors:  Ryota Tamura; Masahiro Toda
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

Review 6.  What MRI can tell us about neurogenic tumors and rhabdomyosarcoma.

Authors:  M Beth McCarville
Journal:  Pediatr Radiol       Date:  2016-05-26

7.  Microsurgery for patients diagnosed with neurofibromatosis type 2 complicated by vestibular schwannomas: Clinical experience and strategy for treatments.

Authors:  Li-Hua Chen; Hong-Tian Zhang; Ru-Xiang Xu; Li Zhang; Wen-De Li; Kai Sun
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

8.  Autonomic Cross-Innervation in Patients With Neurofibromatosis Type 2: Frey Syndrome and Unilateral Epiphora With Rhinorrhea.

Authors:  Erica Evans; David Nascene; Katherine Sommer; Christopher Moertel
Journal:  Child Neurol Open       Date:  2019-08-06

9.  Genetic and immune profiling for potential therapeutic targets in adult human craniopharyngioma.

Authors:  Cynthia Kassab; Daniel Zamler; Carlos Kamiya-Matsuoka; Zoran Gatalica; Joanne Xiu; David Spetzler; Amy B Heimberger
Journal:  Clin Oncol Res       Date:  2019-06-27

Review 10.  The Importance of Early Genetic Diagnostics of Hearing Loss in Children.

Authors:  Nina Božanić Urbančič; Saba Battelino; Tine Tesovnik; Katarina Trebušak Podkrajšek
Journal:  Medicina (Kaunas)       Date:  2020-09-14       Impact factor: 2.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.